Immune Design Corp. (IMDZ)

1.66 0 (0%)

IEX Real-Time Price

October 19, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 1.66

Price Open 1.67

Volume: 1.1M

Avg Volume: 488,138

Market Cap: 79.95M

P/E Ratio -1.2

52 Wk Range 1.47-5.9



IMDZ Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-09-28
47.71M
672,371
3.34
1.41%

2018-09-14
47.71M
709,892
2.35
1.49%

2018-08-31
47.71M
809,373
2.67
1.70%

2018-08-15
47.71M
1.04M
3.67
2.18%




IMDZ Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-01
Q2 2018
N/A
-0.30 (4)
-0.29
0.01

2018-05-03
Q1 2018
N/A
-0.29 (4)
-0.28
0.01

2018-05-02
Q1 2018
AMC
-0.29 (4)
-0.28
0.01

2018-03-14
Q4 2017
AMC
-0.39 (4)
-0.28
0.01

News

Premarket Losers as of 9:05 am (10/12/2018) (2018-10-12 09:09 SeekingAlpha)

IMDZ -41% on announcing updates & portfolio prioritization for G100 and CMB305. More news on: Immune Design, Verastem, Inc., Spherix Incorporated, Stocks on the move, Top stock market news, , Read more …

 


Statistics

Shares Outstanding: 48.16M

Top 15 Institution Percent: 81.60

Price To Sales: 45.87

Price To Book: 0.68

Revenue: 516000

Gross Profit: 500000

Cash: 64.34M

Debt: N/A

Return On Assets: -48.70

Return On Equity: -55.19

Profit Margin: N/A

Price History

Beta: 2.33

50-day Moving Avg: 3.14

200-day Moving Avg: 3.66

YTD Change: -59.51

5-day Change: -2.92

1-month Change: -53.24

3-month Change: -61.40

6-month Change: -52.57

1-year Change: -68.08

Revenue Per Share: 0.00

Revenue Per Employee: 9214.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Immune Design Corp.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.immunedesign.com

Immune Design Corp is a clinical-stage immunotherapy company with next-generation in vivo approaches designed to enable the body's immune system to fight disease.